Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury

Molecular Pharmacology

Volumn 50, Issue 5, 1996, Pages 1065-1072

  Tindberg, Niclas ^a   Baldwin, Helen A ^b   Cross, Alan J ^b   Ingelman Sundberg, Magnus ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORZOXAZONE; CLOMETHIAZOLE; CYTOCHROME P450 ISOENZYME; DACTINOMYCIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; BRAIN MICROSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG HYDROXYLATION; DRUG METABOLISM; ENZYME INDUCTION; INFLAMMATION; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSCRIPTION REGULATION;

ANIMALS; ASTROCYTES; BRAIN ISCHEMIA; CELLS, CULTURED; CEREBRAL CORTEX; CHLORMETHIAZOLE; CHLORZOXAZONE; CYTOCHROME P-450 CYP2E1; ENZYME INDUCTION; ENZYME INHIBITORS; GERBILLINAE; HYDROXYLATION; INFLAMMATION; INTERLEUKIN-1; KINETICS; LIPOPOLYSACCHARIDES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0029808476     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Kalow, W., and R. Tyndale. Debrisoquine/sparteine monooxygenase and other P450s in the brain, in Pharmacogenetics of Drug Metabolism (W. Kalow, ed.). Pergamon Press, New York, 649-656 (1992).
2. Warner, M., and J.-A. Gustafsson. Extrahepatic microsomal forms: brain cytochrome P450, in Handbook of Experimental Pharmacology: Cytochrome P450 (J. Schenkman, ed.). Springer Verlag, Berlin, 387-397 (1993).
3. Hansson T., N. Tindberg, M. Ingelman-Sundberg, and C. Köhler. Regional distribution of cytochrome P450 2E1 in the rat central nervous system. Neuroscience 34:451-463 (1990).
4. Tindberg, N., and M. Ingelman-Sundberg. Expression, catalytic activity and inducibility of CYP2E1 in the rat central nervous system. J. Neurochem., in press (1996).
5. Adams, M. D., M. Dubnick, A. R. Kerlavage, R. Moreno, J. M. Kelley, T. R. Utterback, J. W. Nagle, C. Fields, and J. C. Venter. Sequence identification of 2,375 human brain genes. Nature (Lond.) 355:632-634 (1992).
6. Kharasch, E. D., and K. E. Thummel. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane and methoxyflurane. Anesthesiology 79:795-807 (1993)
7. Terelius, Y., K. O. Lindros, E. Albano, and M. Ingelman-Sundberg. Isozyme-specificity of cytochrome P450 mediated hepatotoxicity. Front. Biotransform. 8:187-232 (1992).
8. Peter, R., R. Böcker, P. H. Beaune, M. Iwasaki, F. P. Guengerich, and C. S. Yang. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450 2E1. Chem. Res. Toxicol. 3:566-573 (1990).
9. Laethem, R. M., M. Balazy, J. R. Falck, C. L. Laethem, and D. R. Koop. Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1. J. Biol. Chem. 268:12912-12918 (1993).
10. Ronis, M. J. J., K. O. Lindros, and M. Ingelman-Sundberg. The cytochrome P4502E subfamily, in Cytochromes P450, Pharmacological and Toxicological Aspects (I. Ioannides, ed.) CRC Press, Boca Raton, Florida, in press (1996).
11. Tindberg, N., and M. Ingelman-Sundberg. Cytochrome P450 and oxygen toxicity. Oxygen-dependent induction of cytochrome P450 2E1 in rat liver and lung. Biochemistry 28:4499-4504 (1989).
12. French, S. W. Rationale for therapy for alcoholic liver disease. Gastroenterology 109:617-20 (1995).
13. Lieberman, A. P., P. M. Pitha, H. S. Shin, and M. L. Shin. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc. Natl. Acad. Sci. USA 86:6348-6352 (1989).
14. Simmons, M. L., and S. Murphy. Induction of nitric oxide synthase in glial cells. J. Neurochem. 59:897-905 (1992).
15. 2 in rat cultured astrocytes. J. Biol. Chem. 266:9956-9960 (1991).
16. Kirino, T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain. Res. 239:57-69 (1982).
17. Giulian, D., and L. B. Lachman. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science (Washington, D. C.) 228:497-499 (1985).
18. Abdel-Razzak, Z., P. Loyer, A. Fautrel, J.-C. Gautier, L. Corcos, B. Turlin, P. Beaune, and A. Guillouzo. Cytokines down-regulate expression of major cytochrome P450 enzymes in adult human hepatocytes in primary culture. Mol. Pharmacol. 44:707-715 (1993).
19. Cribb, A. E., E. Delaporte, S. G. Kim, R. F, Novak, and K. W. Renton. Regulation of cytochrome P4501A and cytochrome P4502E induction in the rat during the production of interferon α/β. J. Pharmacol. Exp. Ther. 268:487-494 (1994).
20. Barker, C. W., J. B. Fagan, and D. S. Pasco. Interleukin-1β suppresses the induction of P450 1A1 and P450 1A2 mRNA in isolated hepatocytes. J. Biol. Chem. 267:8050-8055 (1992).
21. Chen, J. Q., A. Ström, J.-Å. Gustafsson, and E. T. Morgan. Suppression of the constitutive expression of cytochrome P450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. mol. Pharmacol. 47:940-947 (1995).
22. Hansson, E. Astroglia from defined brain regions as studied with primary cultures. Prog. Neurobiol. 30:369-397 (1988).
23. Johansson, I., G. Ekström, B. Scholte, D. Puzycki, H. Jörnvall, and M. Ingelman-Sundberg M. Ethanol-, fasting- and acetone inducible cytochromes P450 in rat liver: regulation and characteristics of enzymes belonging to the 2B and 2E gene subfamilies. Biochemistry 27:1925-1934 (1988).
24. Cross, A. J., J. A. Jones, H. A. Baldwin, and A. R. Green. Neuroprotective activity of chlormethiazole following transient forebrain ischemia in the gerbil. Br. J. Pharmacol. 104:406-411 (1991).
25. Baldwin, H. A., J. L. Williams, M. Snares, T. Ferreira, A. J. Cross, and A. R. Green. Attenuation by chlormethiazole administration of the rise in extracellular amino acids following focal ischemia in the cerebral cortex of the rat. Br. J. Pharmacol. 112:188-194 (1994).
26. Åström, A., W. Birberg, A. Pilotti, and J. W. DePierre. Induction of different isozymes of cytochrome P450 and of microsomal epoxide hydrolase in rat liver by 2-acetylamino-fluorene and structurally related compounds. Eur. J. Biochem. 154:125-34 (1986)
27. Chomczynski, P. and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162:156-159 (1987).
28. Noonan, K. E., C. Beck, T. A. Holzmayer, J. E. Chin, J. S. Wunder, I. L. Andrulis, A. F. Gazdar, C. L. Willman, B. Griffith, D. D. Von Hoff, and I. B. Roninson. Quantitative analysis of MDR1 gene expression in human tumours by polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87: 7160-7164 (1990).
29. Birgersson, C., E. T. Morgan, H. Jörnvall, and C. von Bahr. Purification of a desmethylimipramine and debrisoquine hydroxylating cytochrome P450 from human liver. Biochem. Pharmacol. 35:3165-3166 (1986).
30. Maeda, Y., M. Matsumoto, O. Hori, K. Kuwabara, S. Ogawa, S. D. Yan, T. Ohtsuki, T. Kinoshita, T. Kamada, and D. R. Stern. Hypoxia/reoxygenation-mediated induction of astrocyte interleukin-6: a paracrine mechanism potentially enhancing neuron survival. J. Exp. Med. 180:2297-2308 (1994).
31. Yamazaki, H., Z. Guo, and F. P. Guengerich. Selectivity of cytochrome P450 2E1 in chlorzoxazone 6-hydroxylation. Drug Metab. Dispos. 23:438-440 (1995).
32. Carriere, V., T. Goasduff, D. Ratanasavanh, F. Morel, J. C. Gautier, A. Guillouzo, P. Beaune, and F. Berthou. Both cytochromes P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chem. Res. Toxicol. 6:852-857 (1993)
33. Ono, S., T. Hatanaka, H. Hotta, M. Tsutsui, T. Satoh, and F. J. Gonzalez. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Pharmacogenetics 5:143-150 (1995).
34. Hu, Y., V. Mishin, I. Johansson, C. von Bahr, A. J. Cross, M. J. J. Ronis, T. M. Badger, and M. Ingelman-Sundberg. Chlormethiazole as an efficient inhibitor of cytochrome P450 2E1 expression in rat liver. J. Pharmacol. Exp. Ther. 269:1286-1291 (1994).
35. Chen, J. Q., M. Nikolovakarakashian, A. H. Merrill, and E. T. Morgan. Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes. J. Biol. Chem. 270:25233-25238 (1995).
36. Muntane, J., V. Longo, M. T. Mitjarila, P. G. Gervasi, and M. Ingelman-Sundberg. Effect of carrageenan-induced granuloma on hepatic cytochrome P450 isozymes in rats. Inflammation 19:143-56 (1995).
37. Rothwell, N. J., and J. K. Reiten. Involvement of interleukin-1 and lipocortin-1 in ischemic brain damage. Cerebrovasc. Brain Metab. Rev. 5:178-198 (1993).
38. Giulian, D., J. Woodward, D. Young, J. F. Krebs, and L. B. Lachman. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8:2485-2490 (1988).
39. Iadecola, C., F. Zhang, S. Xu, R. Casey, and M. E. Ross. Inducible NOS gene expression in brain following cerebral ischemia. J. Cereb. Bloodflow. Metab. 15:378-384 (1995).
40. Amruthesh, S. C., M. F. Boerschel, J. S. McKinney, K. A. Willoughby, and E. F. Ellis. Metablism of arachidonic acid to epoxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and prostaglandins in cultured rat hippocampal astrocytes. J. Neurochem. 61:150-159 (1993).